Mannkind (MNKD) Interest Expenses (2010 - 2026)
Mannkind's (MNKD) quarterly Interest Expenses came in at $17.3 million in Q1 2026, up 62.72% year-on-year from $10.6 million in Q1 2025, and down 46.7% on a QoQ basis from $32.5 million in Q4 2025.
Mannkind (MNKD) Interest Expenses (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Interest Expenses data on file, last reported at $17.3 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 62.72% year-over-year to $17.3 million in Q1 2026; TTM through Mar 2026 was $17.3 million, a 70.89% decrease from a year earlier, with the FY2025 full-year figure at $38.0 million, changed 0.13% from the prior year.
- Interest Expenses for Q1 2026 stood at $17.3 million, down from $32.5 million in the prior quarter.
- Over the last five years, Interest Expenses for MNKD reached as high as $32.5 million in Q4 2025 and fell as low as $2.7 million in Q1 2022.
- Historically, Interest Expenses has averaged $10.3 million across 5 years, with a median of $6.9 million in 2023.
- Across the five-year window, Interest Expenses jumped 363.28% in 2023 and plunged 60.48% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $3.7 million in 2022, then soared by 363.28% to $17.2 million in 2023, then jumped by 60.4% to $27.6 million in 2024, then rose by 17.77% to $32.5 million in 2025, then tumbled by 46.7% to $17.3 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $17.3 million in Q1 2026, $32.5 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 17.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.30 Mn |
| Mar 31, 2026 | 17.30 Mn |
| Dec 31, 2025 | 32.46 Mn |
| Dec 31, 2025 | 32.46 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 6.19 Mn |
| Jun 30, 2025 | 6.19 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 27.56 Mn |
| Dec 31, 2024 | 27.56 Mn |
| Sep 30, 2024 | 8.36 Mn |
| Sep 30, 2024 | 8.36 Mn |
| Jun 30, 2024 | 12.88 Mn |
| Jun 30, 2024 | 12.88 Mn |
| Mar 31, 2024 | 9.26 Mn |
| Mar 31, 2024 | 9.26 Mn |
| Dec 31, 2023 | 17.18 Mn |
| Dec 31, 2023 | 17.18 Mn |